These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 7732895

  • 1. ABT-299, a potent antagonist of platelet activating factor.
    Summers JB, Albert DH, Davidsen SK, Conway RG, Holms JH, Magoc TJ, Luo G, Tapang P, Rhein DA, Carter GW.
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():475-7. PubMed ID: 7732895
    [No Abstract] [Full Text] [Related]

  • 2. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist.
    Kruse-Elliott KT, Albert DH, Summers JB, Carter GW, Zimmerman JJ, Grossman JE.
    Shock; 1996 Apr; 5(4):265-73. PubMed ID: 8721386
    [Abstract] [Full Text] [Related]

  • 3. Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist.
    Albert DH, Conway RG, Magoc TJ, Tapang P, Rhein DA, Luo G, Holms JH, Davidsen SK, Summers JB, Carter GW.
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1595-606. PubMed ID: 8667228
    [Abstract] [Full Text] [Related]

  • 4. Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist.
    Albert DH, Magoc TJ, Tapang P, Luo G, Morgan DW, Curtin M, Sheppard GS, Xu L, Heyman HR, Davidsen SK, Summers JB, Carter GW.
    Eur J Pharmacol; 1997 Apr 23; 325(1):69-80. PubMed ID: 9151941
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
    Nagaoka J, Harada K, Kimura A, Kobayashi S, Murakami M, Yoshimura T, Yamada K, Asano O, Katayama K, Yamatsu I.
    Arzneimittelforschung; 1991 Jul 23; 41(7):719-24. PubMed ID: 1663352
    [Abstract] [Full Text] [Related]

  • 8. Ex vivo inhibition of PAF-induced beta-thromboglobulin release in man by ABT-299, a potent PAF antagonist.
    Albert DH, Magoc TJ, Kleinert HD, Sun E, Reyes AE, Carter GW, Summers JB.
    Adv Exp Med Biol; 1996 Jul 23; 416():381-7. PubMed ID: 9131177
    [No Abstract] [Full Text] [Related]

  • 9. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock.
    Terashita Z, Imura Y, Nishikawa K, Sumida S.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Jul 23; 15():715-7. PubMed ID: 3004156
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N, Murakami-Uchida M, Koike H, Natsume Y, Morooka S.
    Arzneimittelforschung; 1994 Mar 23; 44(3):317-22. PubMed ID: 8192697
    [Abstract] [Full Text] [Related]

  • 12. Platelet-activating factor antagonists: scientific background and possible clinical applications.
    Koltai M, Guinot P, Hosford D, Braquet PG.
    Adv Pharmacol; 1994 Mar 23; 28():81-167. PubMed ID: 8080821
    [No Abstract] [Full Text] [Related]

  • 13. N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist.
    Davidsen SK, Summers JB, Albert DH, Holms JH, Heyman HR, Magoc TJ, Conway RG, Rhein DA, Carter GW.
    J Med Chem; 1994 Dec 23; 37(26):4423-9. PubMed ID: 7799395
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the physicochemical properties of the micelles by the novel platelet activating factor receptor antagonist E5880.
    Asai Y, Watanabe S.
    Eur J Pharm Biopharm; 2000 May 23; 49(3):219-23. PubMed ID: 10799812
    [Abstract] [Full Text] [Related]

  • 15. ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats.
    Albert DH, Luo G, Magoc TJ, Tapang P, Holms JH, Davidsen SK, Summers JB, Carter GW.
    Shock; 1996 Aug 23; 6(2):112-7. PubMed ID: 8856845
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z, Kawamura M, Takatani M, Tsushima S, Imura Y, Nishikawa K.
    J Pharmacol Exp Ther; 1992 Feb 23; 260(2):748-55. PubMed ID: 1738121
    [Abstract] [Full Text] [Related]

  • 17. Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion.
    Fukuoka T, Nakajima Y, Horikawa M, Aomatsu Y, Yoshimura A, Ueno M, Ko S, Nakano H.
    Transplant Proc; 1993 Apr 23; 25(2):1809-10. PubMed ID: 8470175
    [No Abstract] [Full Text] [Related]

  • 18. Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists.
    Houlihan WJ, Cheon SH, Parrino VA, Handley DA, Larson DA.
    J Med Chem; 1993 Oct 15; 36(21):3098-102. PubMed ID: 8230095
    [Abstract] [Full Text] [Related]

  • 19. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M, Delaunois A, Gustin P, Godeau JM, Lekeux P.
    Vet Res; 2000 Oct 15; 31(2):267-72. PubMed ID: 10779205
    [Abstract] [Full Text] [Related]

  • 20. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O, Robaut C, Cavero I.
    J Pharmacol Exp Ther; 1988 Feb 15; 244(2):709-15. PubMed ID: 2831350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.